The Life Science Cluster

🎉 Yesterday, we had the pleasure of welcoming students from OsloMet – Oslo Metropolitan University to Forskningsparken - Oslo Science Park! Some of these talented students had participated in our successful HealthHACK event back in March. During their visit, they had the opportunity to attend inspiring company presentations by Dr Nanda Tarte from Alv B AS and Rianne Harmsen from GE HealthCare. Our Interim CEO, Delphine Costa, shared insights about The Life Science Cluster, and Anne-Marie Korseberg Stokke gave an overview of Forskningsparken and the ecosystem here. The students also enjoyed a guided tour, with visits to Startuplab hosted by Henock Sintaye Abeba, ShareLab with Mathea Roti Egli, and Aksel Tunold at Aleap. The day wrapped up with pizza, networking, and some great conversations! A special thanks to the students for their engagement and curiosity, and Kristine Andreassen and Thea Ørneseidet for making this evening possible. We look forward to seeing more from these future innovators in the life science space! 🌟 💡 The HealthHack event, hosted in collaboration between OsloMet Intelligent Health and The Life Science Cluster, brought together students, researchers, and industry experts to develop innovative solutions for healthcare challenges. Check out the details and outcomes of this exciting event here: https://lnkd.in/e3PSUeWg 📸 Anne-Marie Korseberg Stokke / Benjamin Dyhre

🌍 Strengthening Nordic Collaboration for Startups The new NordForsk report, "𝘕𝘰𝘳𝘥𝘪𝘤 𝘈𝘥𝘥𝘦𝘥 𝘝𝘢𝘭𝘶𝘦 𝘪𝘯 𝘐𝘯𝘵𝘦𝘳-𝘮𝘪𝘯𝘪𝘴𝘵𝘦𝘳𝘪𝘢𝘭 𝘕𝘰𝘳𝘥𝘪𝘤 𝘊𝘰-𝘰𝘱𝘦𝘳𝘢𝘵𝘪𝘰𝘯", makes one key recommendation: 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐍𝐨𝐫𝐝𝐢𝐜 𝐜𝐨-𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧. Life Science Academy for Startups (LSA) is a prime example of how working across borders can enhance support for startups in the life science sector. 🤝 LSA is benchmarking the methodology for supporting startups by connecting Denmark, Sweden, and Norway. As one of ten partners, The Life Science Cluster is committed to increasing the investor-readiness of the startups involved in the program. Interested in joining? Members can still participate. Contact Hanne Mette Kristensen to learn more about how LSA can support your startup.

💥 Yesterday, we kicked off an exciting collaboration at Forskningsparken - Oslo Science Park with Kongshavn vgs and their new #Real8slo program! This initiative gives pupils a fantastic chance to immerse themselves in life sciences early on, and we at The Life Science Cluster are thrilled to be collaborating with them to bridge the gap between education and industry. Our goal is to connect these pupils with our network, nurturing the next generation of scientists and innovators. Stay tuned for more updates throughout the year! ✨

𝐌𝐚𝐤𝐞 𝐦𝐞 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐑𝐞𝐚𝐝𝐲 – 𝐜𝐨𝐦𝐩𝐚𝐧𝐲 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐨𝐧 𝐡𝐨𝐰 𝐭𝐨 𝐡𝐚𝐧𝐝𝐥𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 Are you looking for private capital and don’t know how to handle the process? Join for us for a one hour webinar to hear how other companies have managed their investment rounds. 📅 Date: 23rd September 2024 🕐 Time: 10:00-11:00, CET Janne T. Morstøl, CEO of Bliksund and Jonas Hallén, CMO of Calluna Pharma, share their experiences from recent investment rounds: how to prepare for and find the right investors, the due diligence process, negotiating a term-sheet, etc. The talk is moderated by Bartosz Smólczyński, a skilled financial managed advisor and former CFO of several startups and scaleups. 𝐖𝐡𝐨 𝐬𝐡𝐨𝐮𝐥𝐝 𝐚𝐭𝐭𝐞𝐧𝐝? 🚀 Startups and scale-ups 👥 Founders and CEOs 📈 Business Development Professionals 🌐 Anyone eyeing exponential growth through strategic partnerships Norway Health Tech Norwegian Smart Care Cluster Biotech North Oslo Cancer Cluster The Life Science Cluster Register via the link 👇 https://lnkd.in/d2-x2thE

💎 QA Forum: Exploring Internal Audits and Best Practices Yesterday, we gathered to discuss the processes, best practices and importance of internal audits. It was an insightful session filled with valuable discussions and experiences around this essential aspect of quality assurance. We will be hosting more QA Forums for our members in the upcoming months. Interested or want to suggest a topic? Get in touch: https://lnkd.in/d-_DZWhA A big thank you to our members for actively participating and making this forum a success. A special thanks to our guest speaker Pinalee N. SERO AS - The independent control sera specialist Novartis Norge Cellmover Node Pharma Bio-Me Nextera AS Regenics AS Dr Nanda Tarte Delphine Costa Benjamin Dyhre

"ADCs are constructed to bring the chemotherapy to the cancer cells and leave healthy cells unharmed. The problem is, we do not know which patients to treat," says Anette Weyergang, CEO and founder of the Norwegian start-up RAB Diagnostics. RAB Diagnostics is developing a tool to identify which patients benefit from a combined treatment of chemotherapy and antibody-drug conjugates (ADCs). The commercial opportunity for these diagnostic tests is on the rise, as personalised cancer medicine and different combination treatments are becoming the future of cancer care. Oslo University Hospital, University of Oslo, UiO:Livsvitenskap, Inven2, RADFORSK, Oslo Cancer Cluster Incubator. https://lnkd.in/dJcUj6ZQ This article series is produced in collaboration between the Norwegian health clusters Oslo Cancer Cluster, Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster and Biotech North, and funded by Viken fylkeskommune.

Curious about the real value of a patent and how to protect your IP? Don't miss tomorrow's Make Me Investor Ready webinar at 13:00! We'll dive into common IP misconceptions and give you insights from leading experts in the field. Perfect for startups, founders, and business developers looking to scale smartly. Join us tomorrow and sign up here: https://lnkd.in/dJWjPxVv

🌿 Innovating with Nature - optimal bio-resource utilization Join us on September 26th at Forskningsparken - Oslo Science Park as part of Oslo Innovation Week. We'll discuss how environmental management of the Oslofjord can unlock new industrial opportunities and how we can optimize bioresources for food and feed. Are there synergies we can tap into for a sustainable future? 📅 September 26th, 08:30 - 10:30. Sign up for the event here: https://lnkd.in/gx_xF4Wi Aggrator NMBU - Norwegian University of Life Sciences Ard Innovation Pelin Kocatürk Schumacher Hanne Mette Kristensen Benjamin Dyhre Vilde Wettergreen Tone Blixøen

🌍 𝗜𝗺𝗮𝗴𝗶𝗻𝗲 𝗮 𝘄𝗼𝗿𝗹𝗱 𝘄𝗵𝗲𝗿𝗲 𝘀𝘂𝗿𝗳𝗮𝗰𝗲𝘀 𝗮𝗿𝗲 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀𝗹𝘆 𝗱𝗶𝘀𝗶𝗻𝗳𝗲𝗰𝘁𝗲𝗱 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗳𝘂𝗻𝗴𝗶, 𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮, 𝘃𝗶𝗿𝘂𝘀𝗲𝘀, 𝗮𝗻𝗱 𝗮𝗹𝗴𝗮𝗲. Spectrum Blue's innovative technology makes this a reality and could be a game-changer in the fight against future pandemics. 💪🦠   Brage W. Johansen, CEO of Spectrum Blue, is leading the commercialization of a solution that not only reduces the risk of infection but also enhances efficiency in healthcare and beyond. 🏥 Their technology is already showing promising results in hospitals and has caught the attention of institutions like NASA 🚀 and the Viking Museum in Bygdøy 🛡️.   In our latest article in The Start-up Spotlight series, we look closer at how this Norwegian company can make a significant impact on global health and environmental sustainability. 🌱   This article series is produced in collaboration between the Norwegian health clusters Oslo Cancer Cluster, Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster and Biotech North, and funded by Viken fylkeskommune. 🤝 Hanne Mette Kristensen Jutta Heix Sergio Ferreira Line Kjelstrup

𝐈𝐏 𝐌𝐢𝐬𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐢𝐨𝐧𝐬 & 𝐓𝐡𝐞 𝐓𝐫𝐮𝐞 𝐕𝐚𝐥𝐮𝐞 𝐨𝐟 𝐚 𝐏𝐚𝐭𝐞𝐧𝐭: Optimising your IP protection when looking for investment 📅 Date: 29.08.2024 🕐 Time: 13:00 – 14:00 CET 🔍 In this webinar, we will go through the main misconceptions that patent attorneys often see: • You have a patent, so you are free to use your invention, aren’t you? • Getting a patent granted is hard • You need to file many patent applications early in your development work • You want to get your patents granted quickly • Your invention is in the software area, so you won’t be able to get a patent • You need to get ‘world-wide’ protection for your invention 𝐖𝐡𝐨 𝐒𝐡𝐨𝐮𝐥𝐝 𝐀𝐭𝐭𝐞𝐧𝐝? 👥 Startups and scale-ups👩💼 Founders and CEOs 📈 Business Development Professionals 🌐 Anyone eyeing exponential growth through strategic partnerships 🤝 The ‘Investor Readiness Webinar Series 2024’ is part of a collaboration between five clusters within health- and life science aiming to provide increased knowledge of & readiness for the investor universe: Norwegian Smart Care Cluster, Norway Health Tech, Oslo Cancer Cluster, Biotech North, The collaboration is led by The Life Science Cluster Speakers🗣 : Karin Leire - Investment Director, Segulah Medical Acceleration Fredrik Lehmann - Venture Partner, Industrifonden Paul Brady, Julia Coggins & Tom Burt - UK and European Patent Attorneys and Partners at Abel + Imray Read more about our speakers and sign up here: https://lnkd.in/dJWjPxVv Hanne Mette Kristensen Therese Oppegaard Benjamin Dyhre